- Clinical trials test new drugs in many places.
- Few trials reflect people in the United States.
- Black people are often underrepresented in trials.
- Hispanic people are often underrepresented too.
- Asian representation has increased over time.
- White participation has stayed mostly stable.
- Many trials run only in a few regions.
- Parts of Africa and Latin America are left out.
- Researchers say we need more diversity early.
- This change can affect how drugs work.
Difficult words
- clinical trial — A study to test a new medicine.Clinical trials
- underrepresented — Not having enough people from a group.
- representation — The presence or number of a group.
- diversity — Many different kinds of people in a group.
- region — A large area or part of a country.regions
- researcher — A person who studies and tests things.Researchers
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you join a clinical trial?
- Should trials include people from different regions?
Related articles
New device measures blood viscosity in real time
Researchers at the University of Missouri created a non-invasive device that monitors blood viscosity and density in real time using ultrasound and software. It can read blood without drawing samples and may help in diseases like sickle cell.
Lower mGlu5 receptor found across autistic adult brains
A study in The American Journal of Psychiatry found lower availability of a glutamate receptor called mGlu5 across the brains of autistic adults. Researchers used PET, MRI and EEG and say the result could affect future diagnosis and treatment.
Personalized DNA vaccine shows promise against glioblastoma
A phase 1 trial found the personalized DNA vaccine GNOS-PV01 is safe and shows early signs of activity against glioblastoma. The small study at Siteman Cancer Center and WashU Medicine reported immune responses and encouraging clinical outcomes.